|
ARGLU1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.792500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.239510E-03 |
| Normal-vs-Stage2 |
1.159800E-01 |
| Normal-vs-Stage3 |
1.489050E-01 |
| Normal-vs-Stage4 |
7.371400E-01 |
| Stage1-vs-Stage2 |
6.876400E-01 |
| Stage1-vs-Stage3 |
3.5443000000468E-06 |
| Stage1-vs-Stage4 |
1.531410E-01 |
| Stage2-vs-Stage3 |
3.929900E-02 |
| Stage2-vs-Stage4 |
1.194570E-01 |
| Stage3-vs-Stage4 |
5.326600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.815380E-03 |
| Normal-vs-AfricanAmerican |
6.762600E-03 |
| Normal-vs-Asian |
5.357000E-01 |
| Caucasian-vs-AfricanAmerican |
5.007800E-01 |
| Caucasian-vs-Asian |
2.232600E-01 |
| AfricanAmerican-vs-Asian |
1.962800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.644100E-04 |
| Normal-vs-Female |
3.556500E-02 |
| Male-vs-Female |
4.836800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.833700E-02 |
| Normal-vs-Extreme_Weight |
1.397750E-02 |
| Normal-vs-Obese |
2.212300E-02 |
| Normal-vs-Extreme_Obese |
2.814800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.109600E-01 |
| Normal_Weight-vs-Obese |
9.804400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.782000E-01 |
| Extreme_Weight-vs-Obese |
8.722600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.592200E-01 |
| Obese-vs-Extreme_Obese |
6.298000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.622600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.024050E-04 |
| Normal-vs-Age(61-80Yrs) |
1.106290E-02 |
| Normal-vs-Age(81-100Yrs) |
4.166000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.076200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.795800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.780000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.837500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.564800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.826300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.5771999994918E-07 |
| Normal-VS-Type2 PRCC |
5.002300E-02 |
| Normal-VS-KIRP CIMP |
1.642290E-03 |
| Normal-VS-Unclassified PRCC |
3.990200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.62903024403249E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.17710285962858E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
1.638030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.320400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.177600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.79780000000896E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.999800E-01 |
| Normal-vs-N1 |
8.259400E-01 |
| Normal-vs-N2 |
1.672190E-01 |
| N0-vs-N1 |
4.027600E-01 |
| N0-vs-N2 |
2.042400E-01 |
| N1-vs-N2 |
3.491200E-01 |
|
|
